Outpatient administration of idecabtagene vicleucel in relapsed refractory multiple myeloma without planned prophylaxis or remote monitoring. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results